Afuco™ Anti-EGFR ADCC Therapeutic Antibody (Necitumumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to EGFR. Necitumumab (proposed INN) is a monoclonal antibody and an antineoplastic. It binds to the epidermal growth factor receptor (EGFR).
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-119 |
| Pricing | Inquiry |
| Host | Human |
| Target | EGFR |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FC, IP, ELISA, Neut, FuncS, IF |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |